Stéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational Research

...

Stéphane Giraudier

Team leader

Institut de recherche Saint-Louis

Stéphanie CHAMBAUD

Research themes

Research themes

Our team develops translational models to improve the understanding and treatment of Myeloproliferative Neoplasms (MPNs): patient samples, patient-derived cell lines, induced pluripotent stem cells (iPSCs), murine models (transgenic and transplantable), primary cell cultures, next-generation sequencing, lentiviral transduction, cell sorting, and microfluidic-based single-cell DNA analysis. Ongoing projects focus on modeling normal and JAK2V617F-mutated stress hematopoiesis, exploring the bone marrow microenvironment in MPN patients, and studying how clonal selection impacts clinical outcome and therapy response.

  • Myeloproliferative Neoplasms (MPNs)

Research areas

We study the impact of the bone marrow niche in MPNs, particularly its role in regulating mutated hematopoiesis and contributing to treatment resistance.

We investigate clonal dynamics in MPNs under therapeutic pressure and stress conditions, aiming to understand how aggressive subclones emerge and expand.

Stéphane Giraudier's team members

Stéphane Giraudier
Team Leader, Full Professor (PU-PH)
Jean-Jacques Kiladjian
Full Professor (PU-PH)
Bruno Cassinat
Hospital Practitioner (PH)
Pierre Fenaux
Full Professor (PU-PH)
Nabih Maslah
Associate Professor (MCU-PH)
Sarah Awan-Toor
Research Engineer
Laura Velazquez
Research Scientist (CR1)
Bochra Mlayah
Research Assistant
Emmanuelle Verger
Research Engineer
Liu Duanya
PhD Student
Pierre Painsec
Research Assistant
Diego Elrio
Assistant Hospital-University Practitioner (AHU)
Jimena Castorena
Research Engineer
Nelly Bosselut
PH
Louis Drevon
PH

Scientific publications

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms

Nabih Maslah & al, Nat Commun., 2025

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Read the publication
Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis

Ganesan & al, JCI Insight, 2024

Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis
Read the publication
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms

Gou & al, Blood Cancer J, 2024

Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms
Read the publication

Funding